Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials.
Authors
Caffo, OThompson, Catherine
De Santis, M
Kragelj, B
Hamstra, D
Azria, D
Fellin, G
Pappagallo, G
Galligioni, E
Choudhury, Ananya
Affiliation
Medical Oncology Department, Santa Chiara Hospital, Trento, ItalyIssue Date
2016-10-05
Metadata
Show full item recordAbstract
Although radical cystectomy is still considered the standard of care for most localized muscle-invasive bladder cancer (MIBC) patients, bladder-sparing strategies with chemoradiotherapy have demonstrated comparable local control and survival rates when adjusting for tumor stage. We present a pooled analysis of individual patient data out of published trials with gemcitabine-based chemoradiotherapy for MIBC.Citation
Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials. 2016 Radiother OncolJournal
Radiotherapy and OncologyDOI
10.1016/j.radonc.2016.09.006PubMed ID
27720221Type
ArticleLanguage
enISSN
1879-0887ae974a485f413a2113503eed53cd6c53
10.1016/j.radonc.2016.09.006
Scopus Count
Collections
Related articles
- Neoadjuvant Chemotherapy-Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study.
- Authors: Shi H, Zhang W, Bi X, Wang D, Xiao Z, Guan Y, Guan K, Tian J, Bai H, Hu L, Cao C, Jiang W, Hu Z, Zhang J, Chen Y, Zheng S, Feng X, Li C, Li Y, Ma J, Liu Y, Zhou A, Shou J
- Issue date: 2021 Oct
- Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer.
- Authors: Choudhury A, Swindell R, Logue JP, Elliott PA, Livsey JE, Wise M, Symonds P, Wylie JP, Ramani V, Sangar V, Lyons J, Bottomley I, McCaul D, Clarke NW, Kiltie AE, Cowan RA
- Issue date: 2011 Feb 20
- Gemcitabine based trimodality treatment in patients with muscle invasive bladder cancer: May neutrophil lymphocyte and platelet lymphocyte ratios predict outcomes?
- Authors: Hurmuz P, Ozyigit G, Kilickap S, Esen CSB, Akdogan B, Ozen H, Akyol F
- Issue date: 2021 Jun
- Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.
- Authors: Mak RH, Hunt D, Shipley WU, Efstathiou JA, Tester WJ, Hagan MP, Kaufman DS, Heney NM, Zietman AL
- Issue date: 2014 Dec 1
- Radiotherapy concurrent with weekly gemcitabine after transurethral tumor resection in muscle ınvasive bladder cancer.
- Authors: Demirci U, Dızdar O, Cetindag MF, Altınova S, Ozsavran A, Dede DS, Kızılırmak N, Eraslan FA, Yalcın B, Cinkir HY
- Issue date: 2015 Oct-Dec